| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |